Public Health

With the November midterm elections comes changes in Congress and state legislatures. While full election results remain in flux, there is the possibility of a shift from unified Democratic control of the White House and Congress to divided power. A split in political control of the federal government raises big…

This updated fact sheet provides the latest data on the U.S. HIV epidemic, including key trends over time, impact by region and population, and information on the U.S. government’s response.

As the 113th Congress is sworn in, and President Barack Obama begins his second term of office, a comprehensive new Kaiser Family Foundation/Robert Wood Johnson Foundation/Harvard School of Public Health survey queried the public about their priorities for, and views on, a wide range of health and health policy issues.…

Diabetes and obesity have evolved from a national public health concern to a problem of epidemic proportions — a very costly problem. The direct medical costs and the indirect costs of diabetes are estimated at $174 billion yearly. This briefing, sponsored by the Alliance for Health Reform and the United…

On February 15, the Kaiser Family Foundation hosted an event featuring a PBS documentary with former Washington Post correspondent T.R. Reid – U.S. Health Care: The Good News – which explores efforts to provide low-cost, quality health care in the U.S. The film looks at variations in health spending across…

The Affordable Care Act aims to promote higher quality care in part by rewarding – and eventually requiring – the reporting of certain quality measures. Previous efforts suggest that public reporting can add significant value. Yet there are concerns about the best way to measure outcomes and quality, the possible…

How the new health reform law is implemented, and how quickly, depend in part on the results of the November 2 election. Now that the leadership of the House will soon change hands, what might Republicans do with respect to health reform? How might Democrats respond? Apart from reform, how…

Just 7% of low-income countries’ populations have received at least one dose of a COVID-19 vaccine as of December 20, well behind the 40% target for 2021.

Hispanic, Asian, and Black people are more likely than White people to live in households with more than four people, where not everyone will receive a free COVID-19 test from the federal government.

This analysis illustrates the potential total cost of Pfizer and Moderna COVID-19 vaccines, based on their publicly-announced expected prices, once they enter the U.S. commercial market. It compares the average price paid by the federal government for the COVID-19 bivalent boosters to the estimated average commercial prices across different scenarios.